Maravai LifeSciences (MRVI)

• Market cap: $461M
• 1 day: -0.95%
• 5 days: -9.83%
• 1 month: 6.48%
• 3 months: -9.83%
• 6 months: 11.03%
• Year to date: -8.24%
• 1 year: 18.18%
• 5 years: -91.68%
• 10 years: -89.55%
• Sector: Healthcare
• Industry: Biotechnology

About: Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Employees: 435